Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04294277
Title Safety and Efficacy of Pemigatinib in Patients With High-risk Urothelial Cancer After Radical Surgery (PEGASUS)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors European Association of Urology Research Foundation
Indications

ureter transitional cell carcinoma

bladder urothelial carcinoma

renal pelvis transitional cell carcinoma

Therapies

Pemigatinib

Age Groups: adult | senior
Covered Countries

Additional content available in CKB BOOST